首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Transplantation and cellular therapy

缩写:

ISSN:2666-6375

e-ISSN:2666-6367

IF/分区:4.4/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引1861
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Emma P Keane,Fabian N Adri,Isabella S Larizza et al. Emma P Keane et al.
Background: Patients who receive hematopoietic stem cell transplantation (HSCT) undergo complex treatment regimens often accompanied by significant physical and psychological symptom burdens. However, patient access to ps...
Junya Kanda,Fernanda Volt,Hanadi Rafii et al. Junya Kanda et al.
Background: Subsequent neoplasms (SN) are serious late complications after umbilical cord blood transplantation (UCBT). However, population-based comparisons of the incidence and outcomes of SN between Japan and Europe ar...
M Klimentova,L Shelikhova,M Perminova et al. M Klimentova et al.
T-cell acute lymphoblastic leukemia (T-ALL) and lymphoblastic lymphoma (T-LBL) in pediatric patients remains a high-risk hematologic malignancy with suboptimal outcomes in relapsed or refractory cases. Allogeneic hematopoietic stem cell tra...
Taylor L Olson,Eduardo A Trujillo Rivera,Blachy J Dávila Saldaña et al. Taylor L Olson et al.
Background: National and international hematopoietic stem cell transplantation (HSCT) societies recommend the use of early warning systems to detect clinical deterioration after pediatric HSCT. Commonly utilized tools, su...
Sergio Rodriguez-Rodriguez,Anna Olive,Fausto Alfredo Rios-Olais et al. Sergio Rodriguez-Rodriguez et al.
Background: B-cell acute lymphoblastic leukemia (B-ALL) is an aggressive hematological malignancy that often requires allogeneic hematopoietic cell transplant (HCT) for long-term remission. Outcomes after HCT are affected...
Alia Cibich,Gauri Wechalekar,Naranie Shanmuganathan et al. Alia Cibich et al.
Background: Allogeneic hematopoietic stem cell transplant (alloHSCT) has evolved substantially in recent decades, expanding patient access via widespread adoption of increased age limits, alternate mismatched donors, redu...
Sergio Rodriguez-Rodriguez,Maria Queralt Salas,Nihar Desai et al. Sergio Rodriguez-Rodriguez et al.
Background: Frailty is an established predictor of adverse outcomes among older patients undergoing allogeneic hematopoietic cell transplantation (alloHCT), but its prognostic value in younger patients is unclear. ...
Jae Won Yoo,Suejung Jo,Seongkoo Kim et al. Jae Won Yoo et al.
Background: Survival outcomes of pediatric patients with refractory myeloid leukemias who undergo allogeneic hematopoietic stem cell transplantation (HSCT) remain poor. ...